Menu Search
Equities

Respiri Ltd

RSH:ASX

Respiri Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.087
  • Today's Change-0.004 / -4.40%
  • Shares traded906.45k
  • 1 Year change+171.88%
  • Beta-0.2462
Data delayed at least 20 minutes, as of Nov 18 2024 04:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Respiri Ltd had net income fall 23.44% from a loss of 5.78m to a larger loss of 7.13m despite revenues that grew 56.85% from 662.10k to 1.04m over the same period.
Gross margin69.98%
Net profit margin-686.48%
Operating margin-680.22%
Return on assets-152.14%
Return on equity-411.64%
Return on investment-384.52%
More ▼

Cash flow in AUDView more

In 2024, Respiri Ltd increased its cash reserves by 421.94%, or 616.71k. Cash Flow from Financing totalled 9.13m or 879.03% of revenues. In addition the company used 6.64m for operations while cash used for investing totalled 1.89m.
Cash flow per share-0.003
Price/Cash flow per share--
Book value per share0.0023
Tangible book value per share0.0005
More ▼

Balance sheet in AUDView more

Respiri Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 4.23%.
Current ratio1.18
Quick ratio0.3744
Total debt/total equity0.0441
Total debt/total capital0.0423
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.